Heat-Killed Saccharomyces cerevisiae, A Dectin-1 Agonist, Selectively Induces IgG4 Production by Human B Cells

키워드

참고문헌 (64)

1. Brown GD, "Immune recognition. A new receptor for beta-glucans", Nature, 413, pp.36~37 (2001)
2. Willment JA, "The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells", Eur J Immunol, 35, pp.1539~1547 (2005)
3. Taylor PR, "Dectin-1 is required for beta-glucan recognition and control of fungal infection", Nat Immunol, 8, pp.31~38 (2007)
4. Kimberg M, "Dectin-1 and its role in antifungal immunity", Med Mycol, 46, pp.631~636 (2008)
5. Drummond RA, "The role of Dectin-1 in the host defence against fungal infections", Curr Opin Microbiol, 14, pp.392~399 (2011)
6. Romani L., "Immunity to fungal infections", Nat Rev Immunol, 11, pp.275~288 (2011)
7. Hardison SE, "C-type lectin receptors orchestrate antifungal immunity", Nat Immunol, 13, pp.817~822 (2012)
8. Wüthrich M, "Adaptive immunity to fungi", Annu Rev Immunol, 30, pp.115~148 (2012)
9. Casadevall A, "A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens", Adv Immunol, 91, pp.1~44 (2006)
10. McClelland EE, "Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism", J Clin Invest, 120, pp.1355~1361 (2010)
11. Casadevall A, "Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases", Cell Host Microbe, 11, pp.447~456 (2012)
12. Elluru SR, "The protective role of immunoglobulins in fungal infections and inflammation", Semin Immunopathol, 37, pp.187~197 (2015)
13. Zhang K., "Accessibility control and machinery of immunoglobulin class switch recombination", J Leukoc Biol, 73, pp.323~332 (2003)
14. Punnonen J, "Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells", Proc Natl Acad Sci U S A, 90, pp.3730~3734 (1993)
15. Snapper CM, "The immunoglobulin class switch: beyond “accessibility”", Immunity, 6, pp.217~223 (1997)
16. Stavnezer J., "Molecular processes that regulate class switching", Curr Top Microbiol Immuno, 245, pp.127~168 (2000)
17. Fujieda S, "IL-4 plus CD40 monoclonal antibody induces human B cells gamma subclass-specific isotype switch: switching to gamma 1, gamma 3, and gamma 4, but not gamma 2", J Immunol, 155, pp.2318~2328 (1995)
18. Defrance T, "Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A", J Exp Med, 175, pp.671~682 (1992)
19. van Vlasselaer P, "Transforming growth factor-beta directs IgA switching in human B cells", J Immunol, 148, pp.2062~2067 (1992)
20. de Boer BA, "Interleukin-12 suppresses immunoglobulin E production but enhances immunoglobulin G4 production by human peripheral blood mononuclear cells", Infect Immun, 65, pp.1122~1125 (1997)
21. Jeannin P, "IgE versus IgG4 production can be differentially regulated by IL-10", J Immunol, 160, pp.3555~3561 (1998)
22. Satoguina JS, "T regulatory-1 cells induce IgG4 production by B cells: role of IL-10", J Immunol, 174, pp.4718~4726 (2005)
23. Maehara T, "Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease", Ann Rheum Dis, 71, pp.2011~2019 (2012)
24. Akdis CA, "Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs", J Clin Invest, 124, pp.4678~4680 (2014)
25. 박석래, "Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers", Immune Network, 12(6), pp.230~239 (2012), 대한면역학회[DOI]
26. Beom-Seok Seo, "Dectin-1 Stimulation Selectively Reinforces LPS-driven IgG1 Production by Mouse B Cells", Immune Network, 13(5), pp.205~212 (2013), 대한면역학회
27. Seo BS, "Dectin-1 agonist selectively induces IgG1 class switching by LPS-activated mouse B cells", Immunol Lett, 178, pp.114~121 (2016)
28. He B, "CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10", J Immunol, 173, pp.4479~4491 (2004)
29. Agresti A, "c-Rel is a selective activator of a novel IL-4", CD40 responsive element in the human Ig gamma4 germline promoter, 2002, pp.38, 849~859
30. Sinquett FL, "Single nucleotide changes in the human Igamma1 and Igamma4 promoters underlie different transcriptional responses to CD40", J Immunol, 182, pp.2185~2193 (2009)
31. Park SR, "Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes", Eur J Immunol, 31, pp.1706~1715 (2001)
32. 이상훈, "Toll-like Receptor 1", 2 Agonist Pam3CSK4 Suppresses Lipopolysaccharide-driven IgG1 Production while Enhancing IgG2a Production by B Cells, 2018, pp.18(1), 1~18[DOI]
33. Schaffer A, "The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites", J Immunol, 162, pp.5327~5336 (1999)
34. Hermanz-Falcón P, "Cloning of human DECTIN-1, a novel C-type lectin-like receptor gene expressed on dendritic cells", Immunogenetics, 53, pp.288~295 (2001)
35. Willment JA, "Characterization of the human beta -glucan receptor and its alternatively spliced isoforms", J Biol Chem, 276, pp.43818~43823 (2001)
36. Grünebach F, "Molecular and functional characterization of human Dectin-1", Exp Hematol, 30, pp.1309~1315 (2002)
37. Brown GD., "Dectin-1: a signalling non-TLR pattern-recognition receptor", Nat Rev Immunol, 6, pp.33~43 (2006)
38. Heinsbroek SE, "Expression of functionally different dectin-1 isoforms by murine macrophages", J Immunol, 176, pp.5513~5518 (2006)
39. del Pilar Jiménez-A M, "Susceptibility to Coccidioides species in C57BL", 6 mice is associated with expression of a truncated splice variant of Dectin-1 (Clec7a), 2008, pp.9, 338~348
40. Ishizaka A, "The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes", Clin Exp Immunol, 79, pp.392~396 (1990)
41. Ando H, "Utility of ovomucoid-specific IgE concentrations in predicting symptomatic egg allergy", J Allergy Clin Immunol, 122, pp.583~588 (2008)
42. Stapel SO, "Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report", Allergy, 63, pp.793~796 (2008)
43. Aalberse RC, "Immunoglobulin G4: an odd antibody", Clin Exp Allergy, 39, pp.469~477 (2009)
44. James LK, "Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies", J Allergy Clin Immunol, 127, pp.509~516 (2011)
45. Santos AF, "IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens", J Allergy Clin Immunol, 135, pp.1249~1256 (2015)
46. Davies AM, "Human IgG4: a structural perspective", Immunol Rev, 268, pp.139~159 (2015)
47. Aalberse RC, "IgG4 breaking the rules", Immunology, 105, pp.9~19 (2002)
48. Bruhns P, "Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses", Blood, 113, pp.3716~3725 (2009)
49. Akdis CA., "Therapies for allergic inflammation: refining strategies to induce tolerance", Nat Med, 18, pp.736~749 (2012)
50. Summerbell RC., "Epidemiology and ecology of onychomycosis", Dermatology, 194(Suppl 1), pp.32~36 (1997)
51. Lue KH, "Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study", Pediatr Allergy Immunol, 17, pp.408~415 (2006)
52. van Helden PM, "IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A", Br J Haematol, 142, pp.644~652 (2008)
53. van Schouwenburg PA, "IgG4 production against adalimumab during long term treatment of RA patients", J Clin Immunol, 32, pp.1000~1006 (2012)
54. Crescioli S, "IgG4 characteristics and functions in cancer immunity", Curr Allergy Asthma Rep, 16, pp.7~ (2016)
55. Mahajan VS, "IgG4-related disease", Annu Rev Pathol, 9, pp.315~347 (2014)
56. Bozzalla Cassione E, "IgG4-related disease", Curr Opin Rheumatol, 29, pp.223~227 (2017)
57. Khosroshahi A, "Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease", Arthritis Rheum, 62, pp.1755~1762 (2010)
58. Strait RT, "IgG1 protects against renal disease in a mouse model of cryoglobulinaemia", Nature, 517, pp.501~504 (2015)
59. Nimmerjahn F, "Fcgamma receptors as regulators of immune responses", Nat Rev Immunol, 8, pp.34~47 (2008)
60. Barrington R, "The role of complement in inflammation and adaptive immunity", Immunol Rev, 180, pp.5~15 (2001)
61. Dangl JL, "Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies", EMBO J, 7, pp.1989~1994 (1988)
62. van der Neut Kolfschoten M, "Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange", Science, 317, pp.1554~1557 (2007)
63. Karsten CM, "Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1", Nat Med, 18, pp.1401~1406 (2012)
64. Lin SC, "Activation of NF-kappaB", Rel by CD40 engagement induces the mouse germ line immunoglobulin Cgamma1 promoter, 1996, pp.16, 4591~4603

관련 논문AI추천